BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 20857899)

  • 1. A comparison of liquid chromatography-tandem mass spectrometry (LC-MS/MS) and enzyme-multiplied immunoassay technique (EMIT) for the determination of the cyclosporin A concentration in whole blood from Chinese patients.
    Li W; Li R; Liu H; Guo X; Shaikh AS; Li P; Wang B; Guo R; Zhang R
    Biosci Trends; 2017 Sep; 11(4):475-482. PubMed ID: 28845016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin therapeutic drug monitoring: age influence and adverse events.
    Charfi R; Ben Sassi M; Gaies E; Jebabli N; Daghfous R; Trabelsi S
    Tunis Med; 2020 Jan; 98(1):35-40. PubMed ID: 32395775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of New Liquid Chromatography-Mass Spectrometry Method and Enzyme-Multiplied Immunoassay Technique for Routine Therapeutic Drug Monitoring of Vancomycin in Chinese Patients.
    Yuan G; Liu H; Shaikh AS; Zhang R; Li P; Wang B; Guo R
    Clin Lab; 2018 Mar; 64(3):277-285. PubMed ID: 29739110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive bias in mycophenolic acid concentrations determined by the CEDIA assay compared to HPLC-UV method: is CEDIA assay suitable for therapeutic drug monitoring of mycophenolic acid?
    Dasgupta A; Johnson M
    J Clin Lab Anal; 2013 Jan; 27(1):77-80. PubMed ID: 23325745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium.
    Jia Y; Peng B; Li L; Wang J; Wang X; Qi G; Rong R; Wang L; Qiu J; Xu M; Zhu T
    Ther Drug Monit; 2017 Feb; 39(1):29-36. PubMed ID: 27941535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure.
    Hougardy JM; Maufort L; Cotton F; Coussement J; Mikhalski D; Wissing KM; Le Moine A; Broeders N; Abramowicz D
    Clin Kidney J; 2016 Apr; 9(2):319-23. PubMed ID: 26985386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.
    Filler G; Alvarez-Elías AC; McIntyre C; Medeiros M
    Pediatr Nephrol; 2017 Jan; 32(1):21-29. PubMed ID: 26921212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.
    McCune JS; Bemer MJ; Long-Boyle J
    Clin Pharmacokinet; 2016 May; 55(5):551-93. PubMed ID: 26620047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?
    Abd Rahman AN; Tett SE; Staatz CE
    Clin Pharmacokinet; 2014 Mar; 53(3):227-245. PubMed ID: 24327238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.
    Abd Rahman AN; Tett SE; Staatz CE
    Clin Pharmacokinet; 2013 May; 52(5):303-31. PubMed ID: 23475567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
    Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
    J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic drug monitoring of mycophenolate mofetil, sirolimus and cyclosporine at C2].
    Royer B; Davani S; Bérard M; Kantelip JP; Muret P
    Ann Biol Clin (Paris); 2003; 61(3):251-8. PubMed ID: 12805001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.
    Shaw LM; Korecka M; van Breeman R; Nowak I; Brayman KL
    Clin Biochem; 1998 Jul; 31(5):323-8. PubMed ID: 9721429
    [No Abstract]   [Full Text] [Related]  

  • 14. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
    Martiny D; Macours P; Cotton F; Thiry P; Gulbis B
    Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
    Prémaud A; Rousseau A; Picard N; Marquet P
    Ther Drug Monit; 2006 Apr; 28(2):274-7. PubMed ID: 16628144
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.